Biologics is an international, peer-reviewed, open access journal on all areas of biologics derived from both novel and established biotechnologies, published quarterly online by MDPI.
  • Open Access—free to download, share, and reuse content. Authors receive recognition for their contribution when the paper is reused.
  • Rapid Publication: first decisions in 15 days; acceptance to publication in 3 days (median values for MDPI journals in the second half of 2021).
  • Recognition of Reviewers: APC discount vouchers, optional signed peer review, and reviewer names published annually in the journal.
  • Biologics is a companion journal of JCM.
Add your e-mail address to receive forthcoming issues of this journal:
Special Issue in Biologics
Antiviral Peptides - from Discovery to Translation Guest Editor: Kai Hilpert
Deadline: 30 June 2022
Special Issue in Biologics
Public Health Emergencies and Threats: From Vaccine Efficacy to Antimicrobial Resistance Guest Editors: Marco Montalti, Davide Gori
Deadline: 31 July 2022
Special Issue in Biologics
Biological Therapies for Neurodegenerative Diseases Guest Editor: Damian Holsinger
Deadline: 31 August 2022
Special Issue in Biologics
Biotechnology to Address the Challenges of Antimicrobial Resistance Guest Editor: Mark Chambers
Deadline: 30 September 2022
Back to TopTop